Sulindac and Docetaxel in Treating Women With Metastatic or Recurrent Breast Cancer
Completed · Phase 2
Conditions studied: Breast Cancer
In brief
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combining sulindac with docetaxel in treating women who have metastatic or recurrent breast cancer.
Key facts
- Study ID
- NCT00039520
- Run by
- Fox Chase Cancer Center
- People needed
- 10
- Starts
- 2002-01-01
- Expected to finish
- 2008-07-01
- Last updated by the study team
- 2014-05-06
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
Where it is running
- Fox Chase Cancer Center — Philadelphia, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.